|
福島県立医科大学学術成果リポジトリ = Fukushima Medical University Repository >
A 医学部 = School of Medicine >
a10 学術雑誌論文等 = Journal Article >
このアイテムの引用には次の識別子を使用してください:
http://ir.fmu.ac.jp/dspace/handle/123456789/122
|
| タイトル: | Soluble Receptor for Advanced Glycation End Products (RAGE) is a Prognostic Factor for Heart Failure |
| その他のタイトル: | soluble RAGE in heart failure |
| 著者: | Koyama, Yo
Takeishi, Yasuchika
Niizeki, Takeshi
Suzuki, Satoshi
Kitahara, Tatsuro
Sasaki, Toshiki
Kubota, Isao |
| 学内所属: | 循環器・血液内科学講座 |
| 誌名/書名: | Journal of Cardiac Failure |
| 巻: | 14 |
| 号: | 2 |
| 開始ページ: | 133 |
| 終了ページ: | 139 |
| 発行日: | 2008年3月 |
| 抄録: | Background: We recently reported that serum levels of pentosidine, one of the well defined advanced glycation end products (AGE), was an independent prognostic factor for heart failure. Receptor for AGEs (RAGE) is expressed in a variety of tissues, and RAGE has a C-truncated secretory isoform of the receptor protein, termed soluble RAGE. In the present study, we measured serum soluble RAGE levels in patients and examined whether serum soluble RAGE predicts prognosis in patients with heart failure. Methods and Results: Serum soluble RAGE concentration was measured in 160 patients with heart failure by a competitive enzyme-linked immunosorbent assay. Patients were prospectively followed during a median follow-up period of 872 days with endpoints of cardiac death or re-hospitalization. Serum soluble RAGE level increased with advancing NYHA functional class. Serum soluble RAGE level was also higher in patients with cardiac events than in event free patients. From the receiver operating characteristic (ROC) curve analysis, the cut-off value of serum soluble RAGE level was determined as 1220 pg/ml. Kaplan-Meier analysis clearly demonstrated that the high soluble RAGE group had a significantly higher incidence of cardiac events than occurred in the low serum soluble RAGE group (P = 0.0004). In the multivariate Cox proportional hazard analysis, soluble RAGE and serum pentosidine were independent risk factors for cardiac events (soluble RAGE: HR 1.90, 95% CI 1.16 . 3.09, P = 0.010; pentosidine: HR 1.59, 95% CI 1.11 . 2.29, P = 0.012). Conclusions: Serum soluble RAGE level is an independent prognostic factor for heart failure, and this novel marker may be useful for risk stratification of patients with heart failure. |
| 出版者: | Elsevier Inc. |
| 本文の言語: | eng |
| このページのURI: | http://ir.fmu.ac.jp/dspace/handle/123456789/122 |
| 本文URL: | http://ir.fmu.ac.jp/dspace/bitstream/123456789/122/1/JCardFail_14_133.pdf |
| ISSN: | 1071-9164
1532-8414 |
| DOI: | 10.1016/j.cardfail.2007.10.019 |
| PubMed番号: | 18325460 |
| 異版(出版者版等): | http://dx.doi.org/10.1016/j.cardfail.2007.10.019 |
| 権利情報: | Copyright © 2008 Elsevier Inc. All rights reserved. |
| 出現コレクション: | a10 学術雑誌論文等 = Journal Article
|
このリポジトリに保管されているアイテムは、他に指定されている場合を除き、著作権により保護されています。
|
